{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:55:58Z","timestamp":1762271758510,"version":"3.44.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30770602","81371590"],"award-info":[{"award-number":["30770602","81371590"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Jiangsu Province, China","award":["BK2010157","BK2011167"],"award-info":[{"award-number":["BK2010157","BK2011167"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.bbr.2013.10.025","type":"journal-article","created":{"date-parts":[[2013,10,19]],"date-time":"2013-10-19T21:30:17Z","timestamp":1382218217000},"page":"153-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Pyrroloquinoline quinone prevents MK-801-induced stereotypical behavior and cognitive deficits in mice"],"prefix":"10.1016","volume":"258","author":[{"given":"Xingqin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quancheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xindai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shishi","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2013.10.025_bib0005","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1471-4159.2005.03311.x","article-title":"Impaired glutamine metabolism in NMDA receptor hypofunction induced by MK801","volume":"94","author":"Brenner","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2013.10.025_bib0010","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.bbr.2013.10.025_bib0015","article-title":"Persistent deficits in hippocampal synaptic plasticity accompany losses of hippocampus-dependent memory in a rodent model of psychosis","volume":"7","author":"Valentina","year":"2013","journal-title":"Front Integr Neurosci"},{"key":"10.1016\/j.bbr.2013.10.025_bib0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2013.10.025_bib0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0304-3940(95)11515-X","article-title":"The effect of anosmia on MK-801-induced behaviour in mice","volume":"190","author":"Andine","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2013.10.025_bib0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.7123229","article-title":"Focal cortical seizures cause distant thalamic lesions","volume":"218","author":"Collins","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.bbr.2013.10.025_bib0035","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0361-9230(83)90037-0","article-title":"Epileptic\u2019 brain damage in rats induced by sustained electrical stimulation of the perforant path. I. Acute electrophysiological and light microscopic studies","volume":"10","author":"Sloviter","year":"1983","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.bbr.2013.10.025_bib0040","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1523\/JNEUROSCI.07-10-03343.1987","article-title":"Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil","volume":"7","author":"Gill","year":"1987","journal-title":"J Neurosci"},{"issue":"9","key":"10.1016\/j.bbr.2013.10.025_bib0045","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/sj.npp.1300993","article-title":"Glial\u2013neuronal interactions are impaired in the schizophrenia model of repeated MK801 exposure","volume":"31","author":"Kondziella","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"6\u20137","key":"10.1016\/j.bbr.2013.10.025_bib0050","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.neuint.2005.11.019","article-title":"Repeated injection of MK801: an animal model of schizophrenia?","volume":"48","author":"Eyjolfsson","year":"2006","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bbr.2013.10.025_bib0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0893-133X(88)90012-7","article-title":"The current status of the dopamine hypothesis of schizophrenia","volume":"1","author":"Carlsson","year":"1988","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.10.025_bib0060","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbr.2013.10.025_bib0065","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10571-006-9062-8","article-title":"Glutamate and schizophrenia: beyond the dopamine hypothesis","volume":"26","author":"Coyle","year":"2006","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.bbr.2013.10.025_bib0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09552","article-title":"Rethinking schizophrenia","volume":"468","author":"Thomas","year":"2010","journal-title":"Nature"},{"issue":"27","key":"10.1016\/j.bbr.2013.10.025_bib0075","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.2174\/138161205774414538","article-title":"Dopamine\u2013Glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis","volume":"11","author":"de Bartolomeis","year":"2005","journal-title":"Curr Pharm Des"},{"issue":"7321","key":"10.1016\/j.bbr.2013.10.025_bib0080","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/468158a","article-title":"The drug deadlock","volume":"468","author":"Abbott","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2013.10.025_bib0085","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jn\/130.4.719","article-title":"Physiological importance of quinoenzymes and the O-quinone family of cofactors","volume":"130","author":"Stites","year":"2000","journal-title":"J Nutr"},{"key":"10.1016\/j.bbr.2013.10.025_bib0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.nutr.18.1.145","article-title":"Newly discovered redox cofactors: possible nutritional, medical, and pharmacological relevance to higher animals","volume":"18","author":"McIntire","year":"1998","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.bbr.2013.10.025_bib0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0065-3233(01)58003-1","article-title":"Pyrroloquinoline quinone (PQQ) from methanol dehydrogenase and tryptophan tryptophylquinone (TTQ) from methylamine dehydrogenase","volume":"58","author":"Davidson","year":"2001","journal-title":"Adv Protein Chem"},{"key":"10.1016\/j.bbr.2013.10.025_bib0100","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/15230860152664966","article-title":"Pyrroloquinoline quinone (PQQ) and quinoprotein enzymes","volume":"3","author":"Anthony","year":"2001","journal-title":"Antioxid Redox Signaling"},{"key":"10.1016\/j.bbr.2013.10.025_bib0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/abio.1999.4039","article-title":"Characterization of pyrroloquinoline quinone amino acid derivatives by electrospray ionization mass spectrometry and detection in human milk","volume":"269","author":"Mitchell","year":"1999","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bbr.2013.10.025_bib0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/153537020322800205","article-title":"Pyrroloquinoline quinone improves growth and reproductive performance in mice fed chemically defined diets","volume":"228","author":"Steinberg","year":"2003","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.bbr.2013.10.025_bib0115","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/422832a","article-title":"Nutritional biochemistry: a new redox-cofactor vitamin for mammals","volume":"422","author":"Kasahara","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2013.10.025_bib0120","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.2549636","article-title":"Nutritional importance of pyrroloquinoline quinone","volume":"245","author":"Killgore","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.bbr.2013.10.025_bib0125","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1271\/bbb.57.1231","article-title":"Stimulation of nerve growth factor production by pyrroloquinoline quinine and its derivatives in vitro and in vivo","volume":"57","author":"Yamaguchi","year":"1993","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.bbr.2013.10.025_bib0130","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1460-9568.2002.02169.x","article-title":"The essential nutrient pyrroloquinoline quinine may act as a neunprotectant by suppressing peroxynitrite formation","volume":"16","author":"Zhang","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbr.2013.10.025_bib0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-5-20","article-title":"The inhibitory effect of pyrroloquinoline quinine on the amyloid formation and cytotoxicity of truncated alpha-synuclein","volume":"5","author":"Kim","year":"2010","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.bbr.2013.10.025_bib0140","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.bbrc.2006.08.144","article-title":"Pyrroloquinoline quinone (PQQ) prevents fibril formation of a-synuclein","volume":"349","author":"Kobayashi","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.bbr.2013.10.025_bib0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3164\/jcbn.2008005","article-title":"Pyrroloquinoline quinone (PQQ) prevents cognitive deficit caused by oxidative stress in rats","volume":"42","author":"Ohwada","year":"2008","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.bbr.2013.10.025_bib0150","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10337-012-2221-9","article-title":"Analysis of pyrroloquinoline quinone in neurotransmitter amino acid incubations: determination of chemical kinetics","volume":"75","author":"Zhou","year":"2012","journal-title":"Chromatographia"},{"key":"10.1016\/j.bbr.2013.10.025_bib0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10967-010-0845-5","article-title":"Preparation of 99mTc-PQQ and preliminary biological evaluation for the NMDA receptor","volume":"287","author":"Kong","year":"2011","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1016\/j.bbr.2013.10.025_bib0160","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00213-004-1944-1","article-title":"Bimodal effects of MK-801 on locomotion and stereotypy in C57BL\/6 mice","volume":"177","author":"Wu","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.10.025_bib0165","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuroscience.2012.10.026","article-title":"Acute N-methyl-d-aspartate receptor hypofunction induced by MK-801 evokes sex-specific changes in behaviors observed in open-field testing in adult male and proestrus female rats","volume":"228","author":"Feinstein","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2013.10.025_bib0170","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0893-133X(97)00200-5","article-title":"Effects of continuous d-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats","volume":"19","author":"Sams-Dodd","year":"1998","journal-title":"Neuropsychopharmacology"},{"issue":"2\u20133","key":"10.1016\/j.bbr.2013.10.025_bib0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0022-510X(87)90121-3","article-title":"Motor function in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse","volume":"77","author":"Donnan","year":"1987","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.bbr.2013.10.025_bib0180","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ddr.430020204","article-title":"Central sympathomimetic activity of (+)-5-methyl-10, 11-dihydro-5H-dibenzo[a,d]cyclobepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties","volume":"2","author":"Clineschmidt","year":"1982","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.bbr.2013.10.025_bib0185","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0028-3908(90)90015-J","article-title":"d-Serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia","volume":"29","author":"Contreras","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2013.10.025_bib0190","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0022-3565(25)38157-7","article-title":"Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyI-d-aspartic acid. antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats","volume":"265","author":"Criswell","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2013.10.025_bib0195","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0022-3565(25)24082-4","article-title":"MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurutransmission, produces phencyclidine-like behavioral effects in pigeoas, rats and Rhesus monkeys","volume":"245","author":"Koek","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2013.10.025_bib0200","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-2999(79)90279-6","article-title":"Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats","volume":"59","author":"Sturgeon","year":"1979","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2013.10.025_bib0205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF01245040","article-title":"MK-801-induced stereotypy and its antagonism by neuroleptic drugs","volume":"81","author":"Tiedtke","year":"1990","journal-title":"J Neural Transm Gen Sect"},{"key":"10.1016\/j.bbr.2013.10.025_bib0210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF01244915","article-title":"Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization","volume":"91","author":"Murase","year":"1993","journal-title":"J Neural Transm Gen Sect"},{"key":"10.1016\/j.bbr.2013.10.025_bib0215","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0922-4106(95)90173-6","article-title":"Dizocilpine enhances striatal tyrosine hydroxylase and aromatic l-amino acid decarboxylase activity","volume":"289","author":"Hadjiconstantinou","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2013.10.025_bib0220","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0014-2999(95)00837-3","article-title":"NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine-treated rats","volume":"299","author":"Biggs","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2013.10.025_bib0225","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0028-3908(98)00163-4","article-title":"Differential actions of dizocilpine (MK-801) on the mesolimbic and mesocortical dopamine systems: role of neuronal activity","volume":"38","author":"Math\u00e9","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2013.10.025_bib0230","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0006-8993(91)91202-C","article-title":"Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine","volume":"562","author":"Wolf","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2013.10.025_bib0235","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0091-3057(94)90165-1","article-title":"Phencyclidine-induced behavioral sensitization","volume":"47","author":"Xu","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2013.10.025_bib0240","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.pbb.2003.11.002","article-title":"Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2\/3 receptor agonists in mice","volume":"77","author":"Cook","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2013.10.025_bib0245","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.pnpbp.2007.09.008","article-title":"Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague-Dawley rats: a locomotor activity and gene induction study","volume":"32","author":"Kalinichev","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2013.10.025_bib0250","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1126\/science.277.5328.953","article-title":"Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine (see comments)","volume":"277","author":"Jentsch","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbr.2013.10.025_bib0255","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0893-133X(97)00034-1","article-title":"Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat","volume":"17","author":"Jentsch","year":"1997","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.bbr.2013.10.025_bib0260","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0006-3223(91)90171-H","article-title":"The effects of NMDA receptor blockade on the acquisition of a conditioned emotional response","volume":"30","author":"Hoehn-Saric","year":"1991","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.bbr.2013.10.025_bib0265","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0270(94)00173-E","article-title":"Automation of the social interaction test by a video-tracking system: behavioural effects of repeated phencyclidine treatment","volume":"59","author":"Sams-Dodd","year":"1995","journal-title":"J Neurosci Methods"},{"issue":"2\u20133","key":"10.1016\/j.bbr.2013.10.025_bib0270","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s002130100776","article-title":"Sensitization of prepulse inhibition deficits by repeated administration of dizocilpine","volume":"156","author":"Schulz","year":"2001","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.bbr.2013.10.025_bib0275","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.10.025_bib0280","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.pbb.2005.01.012","article-title":"The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating","volume":"80","author":"Buben\u00edkov\u00e1","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2013.10.025_bib0285","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1523\/JNEUROSCI.12-06-02362.1992","article-title":"Interaction of the putative essential nutrient pyrroloquinoline quinine with the N-methyl-d-aspartate receptor redox modulatory site","volume":"12","author":"Aizerman","year":"1992","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2013.10.025_bib0290","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","article-title":"Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism","volume":"67","author":"Porat","year":"2006","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bbr.2013.10.025_bib0295","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.brainres.2006.03.111","article-title":"Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat","volume":"1094","author":"Zhang","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2013.10.025_bib0300","first-page":"268","article-title":"Potential physiological importance of pyrroloquinoline quinine","volume":"14","author":"Rucker","year":"2009","journal-title":"J Altern Med Rev"},{"key":"10.1016\/j.bbr.2013.10.025_bib0305","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/0024-3205(93)90631-C","article-title":"Effects of pyrroloquinoline quinone (PQQ) and PQQ-oxazole on DNA synthesis of cultured human fibroblasts","volume":"52","author":"Naito","year":"1993","journal-title":"Life Sci"},{"issue":"9","key":"10.1016\/j.bbr.2013.10.025_bib0310","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.0805854106","article-title":"MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction","volume":"106","author":"Kocerha","year":"2009","journal-title":"PNAS"},{"issue":"1\u20133","key":"10.1016\/j.bbr.2013.10.025_bib0315","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2012.09.052","article-title":"Effect of pyrroloquinoline quinone on neuropathic pain following chronic constriction injury of the sciatic nerve in rats","volume":"697","author":"Gong","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2013.10.025_bib0320","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1176\/appi.ajp.157.11.1738","article-title":"Novel neurotransmitters and their neuropsychiatric relevance","volume":"157","author":"Snyder","year":"2000","journal-title":"Am J Psychiatry"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813006335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813006335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:03:48Z","timestamp":1759064628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432813006335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":64,"alternative-id":["S0166432813006335"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2013.10.025","relation":{},"ISSN":["0166-4328"],"issn-type":[{"type":"print","value":"0166-4328"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrroloquinoline quinone prevents MK-801-induced stereotypical behavior and cognitive deficits in mice","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2013.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}